1. Home
  2. FOR vs AMPH Comparison

FOR vs AMPH Comparison

Compare FOR & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forestar Group Inc

FOR

Forestar Group Inc

HOLD

Current Price

$30.31

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$28.50

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOR
AMPH
Founded
2005
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2007
2014

Fundamental Metrics

Financial Performance
Metric
FOR
AMPH
Price
$30.31
$28.50
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$31.75
$31.00
AVG Volume (30 Days)
197.6K
297.9K
Earning Date
01-20-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.27
2.27
Revenue
$1,685,000,000.00
$723,305,000.00
Revenue This Year
$0.52
$1.37
Revenue Next Year
$7.72
$4.84
P/E Ratio
$9.27
$12.56
Revenue Growth
15.89
N/A
52 Week Low
$18.00
$20.39
52 Week High
$30.74
$32.69

Technical Indicators

Market Signals
Indicator
FOR
AMPH
Relative Strength Index (RSI) 71.28 57.21
Support Level $29.13 $27.24
Resistance Level $29.87 $29.09
Average True Range (ATR) 0.95 0.89
MACD 0.32 0.08
Stochastic Oscillator 93.22 73.77

Price Performance

Historical Comparison
FOR
AMPH

About FOR Forestar Group Inc

Forestar Group Inc is a residential lot development company engaged in land acquisition and development for the sale of finished single-family residential lots to local, regional, and national homebuilders. The company operates through a single real estate segment, which acquires land, installs infrastructure for residential communities, and generates all revenue from lot sales. Its communities mainly support entry-level, first-time move-up, and active-adult homes, with certain communities also marketed to build-to-rent operators. the company generally invests in entitled, short-duration projects that can be developed in phases to align lot production with market demand and support efficient capital deployment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: